As artificial intelligence (AI) rapidly evolves, it is transforming global industries while spearheading a new wave of technological advancement. One corporation that is strategically navigating this transformation is Guangdong Dongyangguang Pharmaceutical Co., Ltd. (referred to as Dongyangguang Pharmaceutical or DYP). This prominent high-tech enterprise, driven by its commitment to innovation, has embarked on a comprehensive AI strategy to ensure its progress aligns with this technological revolution.

Dongyangguang Pharmaceutical aims to leverage artificial intelligence across multiple dimensions—from developing robust computing infrastructures and AI-enabled drug research pipelines to creating advanced computational models and building a comprehensive AI research ecosystem. The company's multifaceted examination of AI applications has birthed an efficient path termed "AI-enabled industrial implementation," driving enhanced innovation and successful application across various scenarios.

One significant initiative in this digital transformation journey is the HEC-Finder platform, an AI tool developed in collaboration with DeepSeek Technology. The platform focuses on reimagining research knowledge management by tackling the enormous challenges posed by the vast amount of literature and patent data that researchers need to sift through during drug development.

Traditional methods of handling research data have proven inadequate amid the growing complexity and volume of information. As researchers struggle with the slow pace of information retrieval and the disorganization of data, the HEC-Finder platform emerges as a robust solution featuring intelligent literature retrieval and patent analysis capabilities. By integrating massive datasets and employing various data formats from scientific literature, the platform provides centralized and insightful analytics essential for improving research efficiency.

The foundation of the HEC-Finder platform is built upon extensive training datasets comprising drug research literature. This functionality enables researchers to identify research trends and extract valuable insights from extensive literary sources and patent information effectively. The platform allows for automatic updates of patent data, rapid extraction of compound structures, and assesses potential patent infringement, thereby minimizing the associated legal risks. Additionally, its commitment to data security through private deployment ensures that core data assets remain protected while fine-tuning the model for enhanced accuracy in specific domains.

DeepSeek's integration into the HEC-Finder platform is likened to introducing a powerful "intelligence catalyst" fueling the platform's capabilities. Previously, the processing of complex literature and patent inquiries, which encompasses multifaceted knowledge areas, often resulted in imprecise analytics. With DeepSeek's superior reasoning abilities, the platform can now dissect intricate relationships within documents and accurately map connections, enhancing the precision of analytical tasks. For instance, when analyzing literature pertaining to novel pharmaceutical development, DeepSeek can swiftly pinpoint critical technological aspects, innovative highlights, and potential risk factors, providing researchers with precise insights for their decision-making.

Moreover, DeepSeek optimizes the data processing workflow, capable of efficiently filtering, categorizing, and integrating the massive amounts of research data that typically bog down traditional systems. The use of intelligent algorithms allows for swift identification of the most relevant datasets to user needs, drastically reducing processing times and enhancing platform responsiveness. Importantly, it minimizes the computational resources previously needed for complex tasks, alleviating financial burdens while supporting the platform’s sustainable evolution and operational efficiency.

The versatility of the DeepSeek model extends beyond standard text-based data by enabling nuanced analysis of varied formats, including figures and formulas. This capability facilitates more comprehensive analytical support, empowering researchers to navigate industry trends effectively. By leveraging these insights, researchers can make data-driven decisions that enhance their research's scientific rigor and commercial viability.

Looking ahead, DYP's ambitions stretch far beyond the innovations already implemented. Plans are in motion to expand the usage of DeepSeek within diverse projects under the AI4S initiative. This ambitious project enfolds numerous critical stages in drug development, from drug target discovery to molecule design and clinical trial optimization. With DeepSeek's unparalleled capabilities, DYP aims to accelerate the research timelines effectively and bolster the success rates during trials—ultimately leading to more effective treatments for patients.

The integration of the DeepSeek model into the HEC-Finder platform stands as a pivotal milestone in Dongyangguang Pharmaceutical’s venture into the intelligent pharmaceutical domain. This move not only sharpens the company’s competitive edge in research and development but also serves as a valuable reference for advancing smart practices across the pharmaceutical industry. As AI technologies continue to mature and further integrate into business processes, it is anticipated that Dongyangguang Pharmaceutical will achieve even greater accomplishments in the drug development sector.

The ripple effects of AI innovation at Dongyangguang Pharmaceutical reflect its aspirations, extending beyond R&D units into all facets of business operations. The corporation is making strides to introduce AI tools across administrative, production, and sales domains, aiming to evolve into a technology-driven entity at the forefront of innovation. This pursuit is not merely about internal efficiency but represents a broader commitment to high-quality development, positioning itself to embrace emerging technologies while serving as a national enterprise perpetually on the cutting edge. In this pivotal transition, AI not only acts as a catalyst for technical revolution but serves as a testament to Dongyangguang's commitment to thriving in the intelligent era.